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Methods: 
 
The impact of anemia on mortality was studied, and its incre-
mental predictive value was evaluated. Demographic, clinical, and biologic
characteristics at admission, as well as treatments and mortality, were recorded
for 1,410 consecutive patients with acute coronary syndromes. The incre-
mental value of adding anemia information to risk score evaluation was deter-
mined using changes in the appropriateness of Cox models when anemia was
added.
 
Results:
 
 Anemia was detected in 381 patients (27%). They were older, had
more co-morbidities, had higher Global Registry of Acute Coronary Events
(GRACE) risk scores, received fewer guideline-recommended treatments, and,
as a result, had 4-fold higher mortality. When included in a prediction model
based on the GRACE risk score, anemia remained an independent predictor of
mortality. The addition of anemia improved both the discriminatory capacity
and calibration of the models. According to the GRACE risk score, the popu-
lation was divided into 4 groups of different risk levels of <1%, 1% to <5%,
5% to <10%, and > or =10%. The addition of anemia to the model made it
possible to reclassify 9%, 43%, 47%, and 23% of patients into the different
risk categories, respectively.
 
Conclusion:
 
 Our data confirmed that anemia was an independent predic-
tive factor of mortality and had incremental predictive value to the GRACE
score system for early clinical outcomes.
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Background:
 
 Determination of appropriate dosing of antithrombotic drugs
is difficult, and clinical studies to define appropriate monitoring techniques are
needed.
 
Objective:
 
 We compared the endogenous thrombin potential (ETP) in
patients planning to undergo percutaneous coronary intervention (PCI) being
pre-treated with a combination of two or three antiplatelet agents and with
fondaparinux or unfractionated heparin (UFH). Pre-treatment was dependent
upon clinical presentation. Calibrated Automated Thrombography was per-
formed in voluntary blood donors and in patients submitted to PCI. Thrombin
generation was studied in platelet poor plasma by a fluorimetric technique.
 
Patients/Methods:
 
 A total of 152 patients were included. Group 1 patients
were pre-treated with aspirin alone, group 2 were pre-treated with aspirin and
clopidogrel, group 3 were treated with a combination of aspirin, clopidogrel,
and 2.5 mg fondaparinux, group 4 were treated with aspirin, clopidogrel, 2.5
mg fondaparinux, and tirofiban, and group 5 received a bolus of 50 IU/kg
UFH plus antiplatelet agents.
 
Results:
 
 Compared with voluntary blood donors, there was a significant
decrease in ETP in group 2. The addition of fondaparinux (group 3) induced
a 24% decrease in ETP; a further 25% decrease in ETP was observed between
groups 3 and 4. No thrombin generation was observed after UFH treatment.
 
Conclusion:
 
 Assessment of thrombin generation is potentially very useful
in the setting of PCI, where a combination of antiplatelet agents and an anti-
coagulant is mandatory.
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Background:
 
 Cardiac magnetic resonance imaging (MRI) is the gold stan-
dard to quantify the infarct size and the extend of microvascular obstruction in
ST-elevation myocardial infarction (STEMI). ST-segment resolution (STR)
after primary percutaneous intervention (PCI) is currently used to assess the
reperfusion quality in the acute phase myocardial infarction. The relation
between STR and microvascular obstruction evaluated by MRI is unknown.
The aim of this study was to determine the relationship between the ST-seg-
ment resolution, the infarct size and the extend of microvascular obstruction.
 
Methods:
 
 41 patients undergoing primary PCI for STEMI within 6 hours
of symptom onset were prospectively included. ST-segment resolution was
evaluated one hour after reperfusion. MRI was performed in all patients. Com-
plete STR was defined as a STR>70%.
 
Results:
 
 Mean age of the patients was 54 Â± 12 yo, 85 waer males. The
percent of infarct size was 18,6 Â±16% of the left ventricular volume.
Microvascular obstruction was present in 68% of patients. Mean STR was 59
Â± 39% and 14 patients (34%) presented complete STR. A large infarct size
(> 75
 
th
 
 percentile) was associated with anterior localisation and left descending
artery obstruction. STR significantly correlated with infarct size measured by
MRI (r=-0,38 p=0,026). Incomplete STR (<70%) predicted large infarct size
with a sensitivity of 78%, a specificity of 42% and high degree of microvas-
cular obstruction with sensitivity of 80% and specificity of 45%.
 
Conclusion:
 
 STR one hour after primary PCI is associated with the level
of infarct size and microvascular obstruction in STEMI patients. Incomplete
STR after PCI is a strong prognostic marker of large infarct size and high
degree of micro vascular obstruction.
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Background:
 
 The presence of preinfarction angina (PIA) has been shown
to confer cardioprotection after ST segment elevation myocardial infarction
(MI). However, the impact of PIA in non ST segment elevation (NSTEMI)
remains to be determined.
 
Patients and Methods:
 
 From the obseRvatoire des Infarctus de Côte d’Or
(RICO) survey, 1541 consecutive patients admitted in intensive care unit with
a first NSTEMI were included in the study. Patients who experienced chest
pain <7 days before the episode leading to admission were defined as having
PIA. Patients presenting with PIA were compared with patients without PIA.
Prehospital resuscitated cardiac arrest (RCA), incidence of in-hospital ventri-
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